Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

62.99
+0.59000.95%
Volume:749.66K
Turnover:47.15M
Market Cap:6.19B
PE:26.94
High:64.00
Open:62.45
Low:60.53
Close:62.40
Loading ...

Why Sarepta Therapeutics (SRPT) Stock Is Nosediving

StockStory
·
01 Apr

Sarepta price target lowered to $179 from $210 at BofA

TIPRANKS
·
01 Apr

Sarepta Therapeutics Faces Uncertainty Amid FDA Changes, Patient Death, RBC Says

MT Newswires Live
·
01 Apr

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

Dow Jones
·
31 Mar

Sarepta Therapeutics Cut to Sector Perform From Outperform by RBC Capital

Dow Jones
·
31 Mar

Shares of Gene Therapy Makers and Developers Fall After Report That FDA Official Peter Marks Has Resigned

THOMSON REUTERS
·
31 Mar

Solid Biosciences Down 10.5%, Taysha Gene Therapies Down 14%

THOMSON REUTERS
·
31 Mar

Fiery Resignation of Top FDA Official Sparks Biotech Selloff -- Barrons.com

Dow Jones
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

BUZZ-Sarepta Therapeutics falls after reports of FDA official resigning

Reuters
·
31 Mar

RBC Downgrades Sarepta Therapeutics to Sector Perform From Outperform, Adjusts PT to $87 From $161

MT Newswires Live
·
31 Mar

Sarepta Therapeutics Shares Down 3.5% Premarket After RBC Cuts to Sector Perform From Outperform, Cuts PT

THOMSON REUTERS
·
31 Mar

Mizuho Securities Remains a Buy on Sarepta Therapeutics (SRPT)

TIPRANKS
·
31 Mar

Is Sarepta Therapeutics (SRPT) the Best Mid Cap Biotech Stock to Buy?

Insider Monkey
·
30 Mar

How to Play SRPT Stock After Patient Death Post DMD Therapy Infusion

Zacks
·
24 Mar

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

StockStory
·
24 Mar

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

Zacks
·
21 Mar

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More

Zacks
·
21 Mar

Sarepta Therapeutics Is Maintained at Sector Perform by Scotiabank

Dow Jones
·
20 Mar

SRPT Nosedives 27% on Patient Death Following DMD Therapy Infusion

Zacks
·
20 Mar